BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

FMR LLC's Holding History (CIK: 0000315066)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 8,650,000 Value ($000) $9,710 Avg Close — Range —
Q3 2025
Shares 8,650,000 Value ($000) $8,516 Avg Close — Range —
Q2 2025
Shares 9,090,000 Value ($000) $8,463 Avg Close — Range —
Q1 2025
Shares 9,090,000 Value ($000) $8,149 Avg Close — Range —
Q4 2024
Shares 21,126,000 Value ($000) $18,020 Avg Close — Range —
Q3 2024
Shares 23,585,000 Value ($000) $19,693 Avg Close — Range —
Q2 2024
Shares 24,070,000 Value ($000) $19,060 Avg Close — Range —
Q1 2024
Shares 25,570,000 Value ($000) $20,823 Avg Close — Range —
Q4 2023
Shares 26,520,000 Value ($000) $22,460 Avg Close — Range —
Q3 2023
Shares 26,520,000 Value ($000) $19,757 Avg Close — Range —
Q2 2023
Shares 41,010,000 Value ($000) $25,175 Avg Close — Range —
Q1 2023
Shares 18,850,000 Value ($000) $12,014 Avg Close — Range —